CRESPONSE
Live / Applied — First extension granted (statement of use) (as of 26 Nov 2025)
What this means for you
Not registered yet, but its 20 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98560183
- Mark type
- Stylized text
- Filed
- 20 May 2024
- Published for opposition
- 01 Apr 2025
- Attorney of record
- Evan Schechter
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic testing materials, namely, specialized biological tissue culture for medical purposes; medical diagnostic reagents and assays for testing of tissue cultures and biological cultures; medical diagnostic reagents and assays for testing of body fluids; diagnostic test reagents for medical use for testing human cancer tissue; biological preparations for diagnostic purposes for medical purposes; diagnostic agents for medical and pharmaceutical purposes; diagnostic substances for medical purposes; medical diagnostic test strips for cancer analysis; diagnostic kits comprising of medical diagnostic agents, preparations and substances for medical purposes, namely, predicting response to cancer treatment; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; assay samples for medical and pharmaceutical use, namely cancer research; biological tissue cultures for medical purposes
- Class 042 — Scientific and technological services: Laboratory testing of materials in the nature of analysis in the field of cancer testing and pathology; medical research laboratory services; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical product evaluation
- Class 044 — Medical, beauty and agricultural services: Medical testing for diagnostic or treatment purposes; Providing medical testing services in the field of diagnosis and treatment of cancer diseases; medical testing services for diagnostic or treatment purposes in the field of optimization of pharmaceutical treatment for cancer patients; provision of medical information in the field of cancer screening, diagnosis and treatment; health care services for treating cancer; providing medical testing services and information for diagnosis, prognosis and predictive behavior of cancer for research purposes
Owner
- Curesponse Ltd., Tel Aviv, IL
- Curesponse Ltd., Tel Aviv, IL
Prosecution history
- 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Nov 2025 — SOU EXTENSION 1 GRANTED
- 26 Nov 2025 — SOU EXTENSION 1 FILED
- 26 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Apr 2025 — PUBLISHED FOR OPPOSITION
- 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Dec 2024 — NON-FINAL ACTION E-MAILED
- 23 Dec 2024 — NON-FINAL ACTION WRITTEN